Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Balancing Risk: New Systematic Review Explores VTE Prophylaxis in Intracranial Hemorrhage Patients
Moleac at the Forefront of Stroke Recovery at the 10ᵗʰ Ho Chi Minh Stroke Conference
Moleac Joins MCGM 2025 to Support Advancements in Geriatric and Alzheimer’s Care
𝗔𝗦𝗡𝗔 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 | 𝗕𝗮𝗹𝗶, 𝗜𝗻𝗱𝗼𝗻𝗲𝘀𝗶𝗮 | 𝟴 – 𝟭𝟬 𝗔𝘂𝗴𝘂𝘀𝘁 𝟮𝟬𝟮𝟱
Meta-Analysis on NeuroAiD’s Role in Stroke Recovery to Be Featured at ASNA 2025
We are pleased to highlight a featured poster presented by Dr. N. V. Ramani, Chair of the..
Visit Us at AAIC 2025 in Toronto – Booth #1446: Advancing Alzheimer’s Disease Management
Our team is at the Alzheimer’s Association International Conference (AAIC), in Toronto (Canada).
Exercise and Vascular Disease: Key Findings from a Systematic Review on Secondary Prevention and Quality of Life
Join Us at AAIC 2025 in Toronto – Booth 1446: Discover Innovations in Alzheimer’s Disease Care
Moleac is attending the Alzheimer’s Association International Conference (AAIC) from July 27ᵗʰ to 31ˢᵗ, 2025, in Toronto (Canada).
Advancing Alzheimer’s Care: Highlights from the 2025 Scientific Meeting in Singapore
We are delighted to share some key moments from the Scientific Meeting held in Singapore on 28 June 2025.
Highlights from the 2025 Neuro Summit in Bali: Advancing Stroke, TBI, and Alzheimer’s Care
Neuro Summit | Bali, Indonesia | 20–22 June 2025.
We are excited to share the highlights from the Neuro Summit held in Bali from 20 to 22 June 2025.
